image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.5957
-0.888 %
$ 424 M
Market Cap
-5.32
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one SNDL stock under the worst case scenario is HIDDEN Compared to the current market price of 1.6 USD, SNDL Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one SNDL stock under the base case scenario is HIDDEN Compared to the current market price of 1.6 USD, SNDL Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one SNDL stock under the best case scenario is HIDDEN Compared to the current market price of 1.6 USD, SNDL Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
909 M REVENUE
27.63%
-163 M OPERATING INCOME
-165.72%
-177 M NET INCOME
52.59%
-16.6 M OPERATING CASH FLOW
-148.07%
-24.8 M INVESTING CASH FLOW
89.22%
-43.1 M FINANCING CASH FLOW
-3.09%
237 M REVENUE
3.84%
-18.5 M OPERATING INCOME
-282.93%
-19.3 M NET INCOME
-289.29%
22.8 M OPERATING CASH FLOW
384.77%
66.5 M INVESTING CASH FLOW
5039.67%
-9.24 M FINANCING CASH FLOW
1.45%
Balance Sheet SNDL Inc.
image
Current Assets 407 M
Cash & Short-Term Investments 202 M
Receivables 27.1 M
Other Current Assets 178 M
Non-Current Assets 1.07 B
Long-Term Investments 586 M
PP&E 283 M
Other Non-Current Assets 197 M
Current Liabilities 103 M
Accounts Payable 22 M
Short-Term Debt 30.5 M
Other Current Liabilities 50.6 M
Non-Current Liabilities 141 M
Long-Term Debt 136 M
Other Non-Current Liabilities 4.18 M
EFFICIENCY
Earnings Waterfall SNDL Inc.
image
Revenue 909 M
Cost Of Revenue 719 M
Gross Profit 190 M
Operating Expenses 353 M
Operating Income -163 M
Other Expenses 13.7 M
Net Income -177 M
RATIOS
20.95% GROSS MARGIN
20.95%
-17.91% OPERATING MARGIN
-17.91%
-18.99% NET MARGIN
-18.99%
-14.25% ROE
-14.25%
-11.72% ROA
-11.72%
-11.63% ROIC
-11.63%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis SNDL Inc.
image
Net Income -177 M
Depreciation & Amortization 64.9 M
Capital Expenditures -7.93 M
Stock-Based Compensation 15.4 M
Change in Working Capital -32.9 M
Others 79.6 M
Free Cash Flow -24.6 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets SNDL Inc.
image
Wall Street analysts predict an average 1-year price target for SNDL of $2.26 , with forecasts ranging from a low of $0.5 to a high of $3.6 .
SNDL Lowest Price Target Wall Street Target
0.5 USD -68.67%
SNDL Average Price Target Wall Street Target
2.26 USD 41.63%
SNDL Highest Price Target Wall Street Target
3.6 USD 125.61%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership SNDL Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
7. News
These Marijuana Stocks Could Make The Difference In Your Portfolio Marijuana stocks are in the same spot where the market is going to have issues with volatility. Due to the political landscape of passing federal reform or any cannabis laws, the next 4 years will be interesting. At this time most people inside Donald Trump's cabinet are not in favor of legal cannabis. marijuanastocks.com - 2 weeks ago
HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a collaboration agreement (the Agreement) with SNDL Inc. (NASDAQ: SNDL) ("SNDL"), one of the world's largest vertically integrated cannabis companies, to jointly develop Good Manufacturing Practices (GMP) compliant vape cartridges. globenewswire.com - 1 month ago
Top Canadian Cannabis Companies Poised for Market Growth in 2025 The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are projected to reach $50 billion by 2026. This impressive growth is fueled by increasing state-level legalization and the potential for federal reform. Recent headlines, including bipartisan efforts to reschedule cannabis and banking legislation advancements, have renewed investor optimism. As Canadian cannabis companies eye the lucrative U.S. market, their innovative strategies and cross-border partnerships position them for potential success. This week, top Canadian cannabis stocks, including Aurora Cannabis, Cronos Group, and Sundial Growers, are worth watching closely. marijuanastocks.com - 1 month ago
HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce the receipt of an initial purchase order under manufacturing and pricing agreements (the Agreements) with SNDL Inc. (NASDAQ: SNDL) ("SNDL"), one of the world's largest vertically integrated cannabis companies. This collaboration underscores the Company's commitment to expanding its presence in regulated international markets, including the UK, Germany, and Australia. globenewswire.com - 1 month ago
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains. marijuanastocks.com - 2 months ago
SNDL Shows Continued Improved Financials And Free Cash Flow For Q3-2024 SNDL reported improved revenues, profit, and free cash flow for Q3-2024. The company's stock is up 30% over the last year. Investor sentiment on the cannabis sector remains weak Cannabis. seekingalpha.com - 2 months ago
Best Canadian Cannabis Stocks for Your December 2024 Watchlist The cannabis sector recently experienced a pullback after Florida voters did not pass recreational cannabis legalization. This has caused a temporary market dip, creating potential entry points for well-researched investors. Despite setbacks, the U.S. cannabis industry continues to expand. It generated $32 billion in sales in 2023 and is expected to surpass $50 billion by 2030. Federal legalization remains a critical catalyst, with Congress debating key reform bills. The SAFE Banking Act and the potential rescheduling of cannabis under the Controlled Substances Act have dominated recent headlines. Investors should stay informed about these developments to understand their market impact. marijuanastocks.com - 2 months ago
SNDL Appoints New Chief Information Officer and New President, Liquor Division CALGARY, AB , Nov. 21, 2024 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") is pleased to announce the appointments of Phil McBride as Chief Information Officer and Navroop Sandhawalia as President, Liquor Division. "SNDL's success is driven by our commitment to talent density and our leaders are the foundation of our performance culture," said Zach George, Chief Executive Officer of SNDL. prnewswire.com - 3 months ago
3 Marijuana Stocks For Today Watchlist The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues. Each party, Republicans and Democrats, walks a different path to passing comprehensive reform and looking at the sector as a whole. marijuanastocks.com - 3 months ago
SNDL Announces Renewal of Share Repurchase Program CALGARY, AB , Nov. 14, 2024 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that its board of directors (the "Board") has approved the renewal of its share repurchase program (the "Share Repurchase Program") upon the expiry of its current share repurchase program on November 20, 2024. The Share Repurchase Program authorizes the Company to repurchase up to C$100  million (the "Share Repurchase Amount") of its outstanding common shares ("shares") from time to time at prevailing market prices, enabling SNDL to opportunistically return value to shareholders. prnewswire.com - 3 months ago
SNDL, Inc. (SNDL) Q3 2024 Earnings Call Transcript SNDL, Inc. (NASDAQ:SNDL ) Q3 2024 Earnings Conference Call November 5, 2024 10:00 AM ET Company Participants Zachary George - CEO Alberto Paredero - CFO Conference Call Participants Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning, and welcome to SNDL's Third Quarter 2024 Financial Results Conference Call. This morning, SNDL issued a press release announcing their financial results for the 2024 third quarter ended on September 30, 2024. seekingalpha.com - 3 months ago
SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition CALGARY, AB , Nov. 4, 2024 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together with its subsidiaries and affiliates, the "Indiva Group") proceedings under the Companies' Creditors Arrangement Act (Canada) (the "CCAA Proceedings"), it has successfully closed its acquisition of the Indiva Group's business and assets (the "Transaction"), pursuant to an approval and reverse vesting order granted by the Ontario Superior Court of Justice (Commercial List) (the "Court"). The consideration paid by SNDL as part of the Transaction was comprised of a credit bid of all of the indebtedness of the Indiva Group owing to SNDL, the retention of certain liabilities of the Indiva Group, and cash payments sufficient to repay certain priority indebtedness of the Indiva Group and costs associated with the CCAA Proceedings. prnewswire.com - 3 months ago
8. Profile Summary

SNDL Inc. SNDL

image
COUNTRY CA
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 424 M
Dividend Yield 0.00%
Description SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Contact 919–11 Avenue SW, Calgary, AB, T2R 1P3 https://www.sndlgroup.com
IPO Date Aug. 1, 2019
Employees 2516
Officers Ms. Marcie Catherine Kiziak President of Cannabis Retail Mr. Matthew Scott Husson General Counsel & Corporate Secretary Ms. Deanna Garand Vice President of Human Resources Sophie Pilon Corporate Communications Manager Navroop Sandhawalia President of Liquor Division Phil McBride Chief Information Officer Mr. Ryan Hellard Chief Strategy Officer Mr. Tyler Robson President of Cannabis Mr. Zachary Ryan George IV Chief Executive Officer & Non Independent Director Mr. Alberto Paredero-Quiros Chief Financial Officer